Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription

Articles published in Cancer

Retrieve available abstracts of 21 articles:
HTML format
Text format

Single Articles

    September 2017
  1. MCWILLIAMS RR, Foster NR, Mahoney MR, Smyrk TC, et al
    North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma.
    Cancer. 2017;123:3494-3501.
    PubMed     Text format     Abstract available

    June 2017
  2. JOHNSON LM, Valdez JM, Quinn EA, Sykes AD, et al
    Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics.
    Cancer. 2017;123:2352-2359.
    PubMed     Text format     Abstract available

    Analytic inquiry: Validation and practical considerations.
    Cancer. 2017;125.
    PubMed     Text format     Abstract available

  4. HANNA MG, Pantanowitz L
    The role of informatics in patient-centered care and personalized medicine.
    Cancer. 2017;125.
    PubMed     Text format     Abstract available

    April 2017
  5. BURKARD ME, Deming DA, Lauring J
    Using cancer genomics to guide clinical decisions.
    Cancer. 2017;123:1288-1291.
    PubMed     Text format    

    January 2017
  6. TALHOUK A, McConechy MK, Leung S, Yang W, et al
    Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
    Cancer. 2017 Jan 6. doi: 10.1002/cncr.30496.
    PubMed     Text format     Abstract available

    First person: Margaret Spitz, MD, MPH.
    Cancer. 2017;123:9-10.
    PubMed     Text format    

    August 2016
  8. CREUTZIG U, Zimmermann M, Reinhardt D, Rasche M, et al
    Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups.
    Cancer. 2016 Aug 16. doi: 10.1002/cncr.30220.
    PubMed     Text format     Abstract available

  9. DESAI NB, Scott SN, Zabor EC, Cha EK, et al
    Genomic characterization of response to chemoradiation in urothelial bladder cancer.
    Cancer. 2016 Aug 1. doi: 10.1002/cncr.30219.
    PubMed     Text format     Abstract available

    June 2016
  10. ROSS JS, Gay LM, Wang K, Ali SM, et al
    Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
    Cancer. 2016 Jun 10. doi: 10.1002/cncr.30102.
    PubMed     Text format     Abstract available

    May 2016
  11. GALLOWAY-PENA JR, Smith DP, Sahasrabhojane P, Ajami NJ, et al
    The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.
    Cancer. 2016 May 3. doi: 10.1002/cncr.30039.
    PubMed     Text format     Abstract available

    April 2016
  12. PRINTZ C
    BRCA 1/2-negative patients who receive counseling after genetic testing have lower anxiety.
    Cancer. 2016;122:1149.
    PubMed     Text format    

    March 2016
  13. LAWLER M, Gavin A, Salto-Tellez M, Kennedy RD, et al
    Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program.
    Cancer. 2016;122:664-73.
    PubMed     Text format    

    January 2016
  14. BOSSE KR, Maris JM
    Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations.
    Cancer. 2016;122:20-33.
    PubMed     Text format     Abstract available

    October 2015
  15. AL-ROHIL RN, Tarasen AJ, Carlson JA, Wang K, et al
    Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies.
    Cancer. 2015 Oct 19. doi: 10.1002/cncr.29738.
    PubMed     Text format     Abstract available

  16. COHEN SA, Laurino M, Bowen DJ, Upton MP, et al
    Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
    Cancer. 2015 Oct 19. doi: 10.1002/cncr.29758.
    PubMed     Text format     Abstract available

  17. SANFORD RA, Song J, Gutierrez-Barrera AM, Profato J, et al
    High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors.
    Cancer. 2015;121:3422-7.
    PubMed     Text format     Abstract available

    September 2015
  18. LIU SY, Mok T, Wu YL
    Novel targeted agents for the treatment of lung cancer in China.
    Cancer. 2015;121 Suppl 17:3089-96.
    PubMed     Text format     Abstract available

    August 2015
  19. PAL T, Bonner D, Cragun D, Monteiro AN, et al
    A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
    Cancer. 2015 Aug 19. doi: 10.1002/cncr.29645.
    PubMed     Text format     Abstract available

    July 2015
  20. TASIAN SK, Loh ML, Hunger SP
    Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.
    Cancer. 2015 Jul 20. doi: 10.1002/cncr.29573.
    PubMed     Text format     Abstract available

    May 2015
  21. DEEKEN JF, Wang H, Subramaniam D, He AR, et al
    A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies.
    Cancer. 2015;121:1645-53.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Genetics is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.